Intuitive Surgical reported Q1 2026 revenue $2.77 bn and EPS $2.50, surpassing consensus $2.62 bn and $2.12 EPS.
Worldwide da Vinci and Ion procedures rose ~17% YoY, with da Vinci up 16% and Ion up 39%, driving system placements.
Company placed 431 da Vinci systems in the quarter, expanding installed base to 11,395 units, up from 10,189 at end Q4 2025.
Shares fell 1.5% in after‑hours trading despite the beat; CFO flagged rising competition and local tender preferences in China.